Transgenic mice models of AD show the same trend, with an upregulation of Tau phosphorylation and reduced O-GlcNAcylation in the hippocampus, supporting the findings of an imbalance between O-GlcNAcylation and Tau phosphorylation (Gatta et al., 2016). The gene discussed is MAPT; the disease is Alzheimer disease.